Your browser doesn't support javascript.
loading
Selinexor in Combination with R-CHOP for Frontline Treatment of Non-Hodgkin Lymphoma: Results of a Phase I Study.
Seymour, Erlene K; Khan, Husain Yar; Li, Yiwei; Chaker, Mahmoud; Muqbil, Irfana; Aboukameel, Amro; Ramchandren, Radhakrishanan; Houde, Christiane; Sterbis, Golbon; Yang, Jay; Bhutani, Divaya; Pregja, Silvana; Reichel, Kathy; Huddlestun, Amy; Neveux, Colleen; Corona, Kelly; Landesman, Yosef; Shah, Jatin; Kauffman, Michael; Shacham, Sharon; Mohammad, Ramzi M; Azmi, Asfar S; Zonder, Jeffrey A.
Afiliación
  • Seymour EK; Department of Oncology, Wayne State University School of Medicine, Detroit, Michigan.
  • Khan HY; Department of Oncology, Wayne State University School of Medicine, Detroit, Michigan.
  • Li Y; Department of Oncology, Wayne State University School of Medicine, Detroit, Michigan.
  • Chaker M; Department of Oncology, Wayne State University School of Medicine, Detroit, Michigan.
  • Muqbil I; Department of Chemistry, University of Detroit Mercy, Detroit, Michigan.
  • Aboukameel A; Department of Oncology, Wayne State University School of Medicine, Detroit, Michigan.
  • Ramchandren R; Department of Oncology, University of Tennessee, Knoxville, Tennessee.
  • Houde C; Karmanos Cancer Institute, Detroit, Michigan.
  • Sterbis G; Karmanos Cancer Institute, Detroit, Michigan.
  • Yang J; Department of Oncology, Wayne State University School of Medicine, Detroit, Michigan.
  • Bhutani D; Department of Oncology, Columbia University, New York, New York.
  • Pregja S; Karmanos Cancer Institute, Detroit, Michigan.
  • Reichel K; Department of Oncology, Wayne State University School of Medicine, Detroit, Michigan.
  • Huddlestun A; Karmanos Cancer Institute, Detroit, Michigan.
  • Neveux C; Karmanos Cancer Institute, Detroit, Michigan.
  • Corona K; Karyopharm Therapeutics Inc., Newton, Massachusetts.
  • Landesman Y; Karyopharm Therapeutics Inc., Newton, Massachusetts.
  • Shah J; Karyopharm Therapeutics Inc., Newton, Massachusetts.
  • Kauffman M; Karyopharm Therapeutics Inc., Newton, Massachusetts.
  • Shacham S; Karyopharm Therapeutics Inc., Newton, Massachusetts.
  • Mohammad RM; Department of Oncology, Wayne State University School of Medicine, Detroit, Michigan.
  • Azmi AS; Department of Oncology, Wayne State University School of Medicine, Detroit, Michigan. zonderj@karmanos.org azmia@karmanos.org.
  • Zonder JA; Department of Oncology, Wayne State University School of Medicine, Detroit, Michigan. zonderj@karmanos.org azmia@karmanos.org.
Clin Cancer Res ; 27(12): 3307-3316, 2021 06 15.
Article en En | MEDLINE | ID: mdl-33785483
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Linfoma no Hodgkin / Protocolos de Quimioterapia Combinada Antineoplásica Tipo de estudio: Observational_studies Límite: Animals / Humans Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2021 Tipo del documento: Article Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Linfoma no Hodgkin / Protocolos de Quimioterapia Combinada Antineoplásica Tipo de estudio: Observational_studies Límite: Animals / Humans Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2021 Tipo del documento: Article Pais de publicación: Estados Unidos